Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.

Gao D, Ning N, Niu X, Dang Y, Dong X, Wei J, Zhu C.

Am Heart J. 2012 Nov;164(5):715-727.e1. doi: 10.1016/j.ahj.2012.07.031. Epub 2012 Oct 16. Review.

PMID:
23137502
[PubMed - indexed for MEDLINE]
3.

Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Singh M, Shah T, Khosla K, Singh P, Molnar J, Khosla S, Arora R.

Ther Adv Cardiovasc Dis. 2012 Jun;6(3):101-14. doi: 10.1177/1753944712446670. Epub 2012 May 4. Review.

PMID:
22562999
[PubMed - indexed for MEDLINE]
4.

Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.

Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ.

JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. doi: 10.1016/j.jcmg.2009.09.014. Epub 2010 Jan 12. Erratum in: JACC Cardiovasc Imaging. 2010 Jul;3(7):796. Velleti, Uma S [corrected to Valeti, Uma S].

PMID:
20129531
[PubMed - indexed for MEDLINE]
Free Article
5.

Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials.

Kang S, Yang YJ, Li CJ, Gao RL.

Coron Artery Dis. 2008 Aug;19(5):327-35. doi: 10.1097/MCA.0b013e328300dbd3. Review.

PMID:
18607170
[PubMed - indexed for MEDLINE]
6.

Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.

Najjar SS, Rao SV, Melloni C, Raman SV, Povsic TJ, Melton L, Barsness GW, Prather K, Heitner JF, Kilaru R, Gruberg L, Hasselblad V, Greenbaum AB, Patel M, Kim RJ, Talan M, Ferrucci L, Longo DL, Lakatta EG, Harrington RA; REVEAL Investigators.

JAMA. 2011 May 11;305(18):1863-72. doi: 10.1001/jama.2011.592.

PMID:
21558517
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.

Ludman AJ, Yellon DM, Hasleton J, Ariti C, Babu GG, Boston-Griffiths E, Venugopal V, Walker M, Holdright D, Swanton H, Crake T, Brull D, Moon JC, Puranik R, Muthurangu V, Taylor A, Hausenloy DJ.

Heart. 2011 Oct;97(19):1560-5. doi: 10.1136/hrt.2011.223867. Erratum in: Heart. 2011 Nov;97(21):1812. Mutharangu, Vivek [corrected to Muthurangu, Vivek].

PMID:
21900585
[PubMed - indexed for MEDLINE]
8.

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials.

Delewi R, Andriessen A, Tijssen JG, Zijlstra F, Piek JJ, Hirsch A.

Heart. 2013 Feb;99(4):225-32. doi: 10.1136/heartjnl-2012-302230. Epub 2012 Aug 8. Review.

PMID:
22875736
[PubMed - indexed for MEDLINE]
9.

High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study.

Ferrario M, Arbustini E, Massa M, Rosti V, Marziliano N, Raineri C, Campanelli R, Bertoletti A, De Ferrari GM, Klersy C, Angoli L, Bramucci E, Marinoni B, Ferlini M, Moretti E, Raisaro A, Repetto A, Schwartz PJ, Tavazzi L.

Int J Cardiol. 2011 Feb 17;147(1):124-31. doi: 10.1016/j.ijcard.2009.10.028. Epub 2009 Nov 10.

PMID:
19906454
[PubMed - indexed for MEDLINE]
10.

Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trial.

Minamino T, Toba K, Higo S, Nakatani D, Hikoso S, Umegaki M, Yamamoto K, Sawa Y, Aizawa Y, Komuro I; EPO-AMI-II study investigators.

Cardiovasc Drugs Ther. 2012 Oct;26(5):409-16. doi: 10.1007/s10557-012-6410-4.

PMID:
22940818
[PubMed - indexed for MEDLINE]
11.

Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial.

Prunier F, Bière L, Gilard M, Boschat J, Mouquet F, Bauchart JJ, Charbonnier B, Genée O, Guérin P, Warin-Fresse K, Durand E, Lafont A, Christiaens L, Abi-Khalil W, Delépine S, Benard T, Furber A.

Am Heart J. 2012 Feb;163(2):200-7.e1. doi: 10.1016/j.ahj.2011.11.005.

PMID:
22305837
[PubMed - indexed for MEDLINE]
12.

Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials.

Zhang S, Sun A, Xu D, Yao K, Huang Z, Jin H, Wang K, Zou Y, Ge J.

Clin Cardiol. 2009 Aug;32(8):458-66. doi: 10.1002/clc.20575. Review.

PMID:
19685520
[PubMed - indexed for MEDLINE]
13.
14.

Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling.

Appleton DL, Abbate A, Biondi-Zoccai GG.

Catheter Cardiovasc Interv. 2008 May 1;71(6):772-81. doi: 10.1002/ccd.21468. Review.

PMID:
18415952
[PubMed - indexed for MEDLINE]
16.

Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat.

Hale SL, Sesti C, Kloner RA.

J Cardiovasc Pharmacol. 2005 Aug;46(2):211-5.

PMID:
16044033
[PubMed - indexed for MEDLINE]
17.

Creatine and creatine analogues in hypertension and cardiovascular disease.

Horjus DL, Oudman I, van Montfrans GA, Brewster LM.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD005184. doi: 10.1002/14651858.CD005184.pub2. Review.

PMID:
22071819
[PubMed - indexed for MEDLINE]
18.

A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).

Jang IK, Weissman NJ, Picard MH, Zile MR, Pettigrew V, Shen S, Tatsuno J, Hibberd MG, Tzivoni D, Wackers FJ; EVOLVE Investigators.

Am Heart J. 2008 Jan;155(1):113.e1-8. Epub 2007 Nov 1.

PMID:
18082500
[PubMed - indexed for MEDLINE]
19.

[Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].

Konermann M, Odenthal HJ, Altmann C, Laschewski F, Rawert B, Trappe HJ, Sanner BM.

Wien Med Wochenschr. 2000;150(12):249-55. German.

PMID:
11008329
[PubMed - indexed for MEDLINE]
20.

Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials.

Sun T, Zhou WB, Luo XP, Tang YL, Shi HM.

Clin Cardiol. 2009 Nov;32(11):649-52. doi: 10.1002/clc.20616.

PMID:
19938054
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk